Roman Maslennikov
Overview
Explore the profile of Roman Maslennikov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Maslennikov R, Poluektova E, Zolnikova O, Sedova A, Kurbatova A, Shulpekova Y, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003692
Cirrhosis is the end result of liver fibrosis in chronic liver diseases. Studying the mechanisms of its development and developing measures to slow down and regress it based on this...
12.
Efremova I, Maslennikov R, Poluektova E, Zharkova M, Kudryavtseva A, Krasnov G, et al.
Microorganisms
. 2023 Sep;
11(9).
PMID: 37764046
The aim was to evaluate the relationship between gut dysbiosis and hemodynamic changes (hyperdynamic circulation) in cirrhosis, and between hemodynamic changes and complications of this disease. This study included 47...
13.
Kovaleva A, Poluektova E, Maslennikov R, Karchevskaya A, Shifrin O, Kiryukhin A, et al.
J Clin Med
. 2023 Sep;
12(18).
PMID: 37763004
Treatment of functional digestive disorders is not always effective. Therefore, a search for new application points for potential drugs is perspective. Our aim is to evaluate the effect of rebamipide...
14.
Kovaleva A, Poluektova E, Maslennikov R, Karchevskaya A, Shifrin O, Kiryukhin A, et al.
Dig Dis Sci
. 2023 Sep;
68(11):4166-4174.
PMID: 37752368
Background: Disturbances in the intestinal barrier and gut dysbiosis have been observed in patients with functional bowel diseases. Aims: To investigate the correlation between biomarkers of intestinal barrier disorders at...
15.
Pontes-Silva A, Kovaleva O, Gadzhiakhmedova A, Luchina A, Sinelnikov M, Maslennikov R, et al.
Rev Assoc Med Bras (1992)
. 2023 Sep;
69(9):e20230721.
PMID: 37729382
No abstract available.
16.
Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, et al.
World J Gastroenterol
. 2023 Aug;
29(27):4236-4251.
PMID: 37545638
Decreased muscle mass and function, also known as sarcopenia, is common in patients with cirrhosis and is associated with a poor prognosis. Although the pathogenesis of this disorder has not...
17.
Cao X, Zolnikova O, Maslennikov R, Reshetova M, Poluektova E, Bogacheva A, et al.
Metabolites
. 2023 Jul;
13(7).
PMID: 37512565
The objective of this study was to investigate the metabolic activity of the gut microbiota in cirrhosis due to different variants of fatty liver disease (alcoholic vs. non-alcoholic [metabolic-associated] one...
18.
Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, et al.
World J Gastroenterol
. 2023 Jun;
29(22):3400-3421.
PMID: 37389240
Small intestinal bacterial overgrowth (SIBO) is defined as an increase in the bacterial content of the small intestine above normal values. The presence of SIBO is detected in 33.8% of...
19.
Efremova I, Maslennikov R, Alieva A, Poluektova E, Ivashkin V
Microorganisms
. 2023 Apr;
11(4).
PMID: 37110440
Background: Small intestinal bacterial overgrowth (SIBO) is associated with numerous manifestations of cirrhosis. To determine whether the presence of SIBO affects the prognosis in cirrhosis was the aim of the...
20.
Dmitrieva K, Maslennikov R, Vasilieva E, Aliev S, Bakhitov V, Marcinkevich V, et al.
J Infect Public Health
. 2023 Apr;
16(6):922-927.
PMID: 37086551
Objectives: The aim is to study impact of vaccination against the novel coronavirus disease (COVID-19) with Sputnik V on mortality during the period of predominance of the delta variant of...